Class microfiber histamine assay device

• US 5,468,650 A
• Filed: 02/28/1994
• Issued: 11/21/1995
• Est. Priority Date: 10/17/1988
• Status: Expired due to Fees

• Current Assignee: A/S Lundbeck Export Division, Ltd.
• Original Assignee: A/S Lundbeck Export Division, Ltd.
• Inventors: Bjarno, Ole-Christian, Skov, Per Stahl
• Primary Examiner(s): Scheiner, Toni R.
• Assistant Examiner(s): Parsons, Nancy J.
• Application Number:
  US08/203,683
• Time in Patent Office: 631 Days
• Field of Search: 435/7.1, 435/287, 435/810, 435/961, 435/962, 436/523, 436/527, 436/169, 422/58, 422/61, 427/180, 427/189, 427/196, 427/214, 427/215, 427/220
• US Class Current: 436/527
• CPC Class Codes: G01N 33/54393 Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
• CPC Class Codes: G01N 33/545 Synthetic resin
• CPC Class Codes: G01N 33/552 Glass or silica
• CPC Class Codes: G01N 33/6863 Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
• CPC Class Codes: G01N 33/74 involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
• CPC Class Codes: Y10S 435/81 Packaged device or kit
• CPC Class Codes: Y10S 435/962 Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding

Abstract

A histamine diagnostic assay device is provided in which glass microfibers treated with a polar organic polymer are deposited onto a carrier and used to selectively bind histamine in a sample. The polar organic polymer reduces the affinity of the glass microfibers for interfering components of the sample while substantially retaining the histamine-binding capacity. Preferably, the glass microfibers are provided as a conglomerate with the polar organic polymer. An agent which induces the release of histamine from cells in the sample may be included in the device.

Claims

1. In a diagnostic test device for use in an assay for histamine comprising a plurality of crushed glass microfibers which hinds histamine and which are deposited onto a carrier,

the improvement which comprises that the crushed glass microfibers have been conglomerated by a binder which reduces the affinity of the conglomerated crushed glass microfibers towards interfering components in a sample while their histamine-binding capacity is substantially retained;

said binder being a polar organic polymer having a solubility parameter sphere substantially encompassing the solubility parameters for histamine.

2. The test device according to claim 1, wherein a binder is used which reduces the polarity or surface tension of the surface of the microfibers.

3. The diagnostic test device according to claim 1, wherein the crushed glass microfibers comprise a soda-lime glass or a borosilicate glass material.

4. The diagnostic test device according to claim 1, wherein the polar organic polymer comprises a polymer containing heteroatoms selected from the group consisting of oxygen and nitrogen atoms.

5. The diagnostic test device according to claim 1 wherein the polar organic polymer is selected from the group consisting of polyvinyl acetate, a vinyl acetate/ethylene copolymer, and polyvinyl alcohol.

6. The diagnostic test device according to claim 1, additionally comprising an agent which induces the release of histamine from cells such that cells brought into contact with the conglomerate of crushed glass microfibers will also be brought in contact with the agent.

7. The diagnostic test device according to claim 6, wherein the histamine release-inducing agent is an allergen.

8. The diagnostic test device according to claim 6, wherein the histamine release inducing agent is anti-IgE.

9. The diagnostic test device according to claim 1, wherein said device is a microtiter tray having individual wells, and wherein the conglomerated crushed glass microfibers are fixed within said wells.

10. The diagnostic test device according to claim 6, wherein said device is a microtiter tray having individual wells, and wherein said conglomerates are fixed within said wells, and wherein at least one of said wells additionally contains an agent which induces the release of histamine.

11. The diagnostic test device according to claim 1, wherein the length of said crushed glass microfibers is about 0.1 to about 200 μ

m.

12. The diagnostic test device according to claim 6, wherein the length of said crushed glass microfibers is about 0.1 to about 200 μ

m.

13. In a method for preparing a diagnostic test device for use in determination of histamine, wherein crushed glass microfibers which bind histamine and are suspended in a liquid are deposited and fixed onto a carrier,

the improvement which comprises mixing the crushed glass microfibers with a binder distributed in the liquid, said binder being a polar organic polymer having a solubility parameter sphere substantially encompassing the solubility parameter for histamine;

and

drying the resulting mixture to obtain a solid conglomerate deposited and fixed onto said carrier.

14. The method of claim 13, wherein the length of said crushed glass microfibers is about 0.1 to about 200 μ

m.